首页 > 市场调查报告书 > 製药

再生医学

市场调查报告书

商品编码

1547697

全球富血小板血浆市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势与预测

Global Platelet Rich Plasma Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年07月01日 | 出版商:

Value Market Research | 英文 170 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录图表

预计到2032年，全球富血小板血浆市场的市场规模将从2023年的4.3158亿美元达到近11.7297亿美元，2024-2032年研究期间的复合年增长率为11.75%。

富含血小板的血浆（PRP）是人体血液的一种成分，含有能够促进血液凝固的蛋白质，并且可以促进其来源的人的癒合。当 PRP 注入受损组织时，它会刺激身体生长新的健康细胞，从而促进癒合。 PRP 的製备方法是从人体内抽取血液，然后将其经过两个阶段的离心，将 PRP 与红血球和贫血小板血浆分离。 PRP 疗法可治疗患有慢性肌腱炎、骨关节炎、肌腱损伤、急性损伤、脱髮、口腔手术和整形手术的患者。这种疗法不会立即产生效果。

市场动态

PRP 疗法的各种优势，如疼痛很少或无痛、恢復更快、手术后不会留下疤痕组织，是该市场成长的关键驱动力。这种疗法的简单性将进一步推动其替代移植的使用。运动相关伤害发生率的上升和整容手术的普及将推动该市场的成长。 PRP 在老年人群中越来越受欢迎，因为该过程绝对不存在感染或过敏反应的风险。人们越来越认识到富血小板血浆治疗牙齿健康的效率将成为市场的助力。 PRP 的一个主要缺点是它对肘部、肌肉和肌腱以外的区域无效。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具也对全球富血小板血浆市场的各个细分市场进行了包容性评估。富血小板血浆产业的成长和趋势为本研究提供了整体方法。

市场区隔

富血小板血浆市场报告的这一部分提供了国家和区域层面细分市场的详细资料，从而帮助策略师确定相应产品或服务的目标人口统计数据以及即将到来的机会。

按类型

纯PRP
富含白血球的PRP
纯PRF

按产地

自体
同种异体
同源

按申请

骨科手术
整容手术
一般外科
神经外科
其他的

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲富血小板血浆市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。富血小板血浆市场的主要参与者包括 Zimmer Biomet Holdings Inc.、AdiStem Ltd.、ISTO Biologics、ThermoGenesis Holdings Inc.、Stryker Corporation、Exactech Inc.、EmCyte Corporation、Regen Lab、Arthrex Inc.、Terumo BCT, Inc.。 (Terumo Corporation)、DePuy Synthes Companies (Johnson & Johnson)、APEX Biologix LLC。本节包含竞争格局的整体视图，包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

区域展望
介绍
北美销售分析
- 概览、历史与预测资料销售分析
- 北美按细分市场销售分析
- 北美按国家销售分析
- 美国销售分析
- 加拿大销售分析
- 墨西哥销售分析
欧洲销售分析
- 概览、历史与预测资料销售分析
- 欧洲按细分市场销售分析
- 欧洲按国家销售分析
- 英国销售分析
- 法国销售分析
- 德国销售分析
- 义大利销售分析
- 俄罗斯销售分析
- 欧洲其他地区销售分析
亚太地区销售分析
- 概览、历史与预测资料销售分析
- 亚太地区按细分市场销售分析
- 亚太地区按国家销售分析
- 中国销售分析
- 印度销售分析
- 日本销售分析
- 韩国销售分析
- 澳洲销售分析
- 东南亚销售分析
- 亚太地区其他地区销售分析
拉丁美洲销售分析
- 概览、历史与预测资料销售分析
- 拉丁美洲按细分市场销售分析
- 拉丁美洲按国家销售分析
- 巴西销售分析
- 阿根廷销售分析
- 秘鲁销售分析
- 智利销售分析
- 拉丁美洲其他地区销售分析
中东和非洲销售分析
- 概览、历史与预测资料销售分析
- 中东和非洲按细分市场销售分析
- 中东和非洲按国家销售分析
- 沙乌地阿拉伯销售分析
- 阿联酋销售分析
- 以色列销售分析
- 南非销售分析
- 中东其他地区和非洲销售分析

第 9 章：富血小板血浆公司的竞争格局

富血小板血浆市场竞争
伙伴关係/协作/协议
併购
新产品发布
其他发展

第 10 章：公司简介

顶级公司市占率分析
市场集中度
Zimmer Biomet Holdings Inc.

公司概况
公司收入
产品
最新动态

AdiStem Ltd.

公司概况
公司收入
产品
最新动态

ISTO Biologics

公司概况
公司收入
产品
最新动态

ThermoGenesis Holdings Inc.

公司概况
公司收入
产品
最新动态

Stryker Corporation

公司概况
公司收入
产品
最新动态

Exactech Inc.

公司概况
公司收入
产品
最新动态

EmCyte Corporation

公司概况
公司收入
产品
最新动态

Regen Lab

公司概况
公司收入
产品
最新动态

Arthrex Inc.

公司概况
公司收入
产品
最新动态

Terumo BCT Inc. (Terumo Corporation)

公司概况
公司收入
产品
最新动态

DePuy Synthes Companies (Johnson & Johnson)

公司概况
公司收入
产品
最新动态

APEX Biologix LLC

公司概况
公司收入
产品
最新动态

註 - 在公司概况中，财务详细资讯和最新发展视情况而定，或对私人公司而言可能不包括在内

简介目录图表

Product Code: VMR11213862

The global demand for Platelet Rich Plasma Market is presumed to reach the market size of nearly USD 1172.97 Million by 2032 from USD 431.58 Million in 2023 with a CAGR of 11.75% under the study period 2024-2032.

Platelet-rich plasma, or PRP, is a component of human blood that contains proteins to enable blood clotting and can promote healing in a person it is derived from. When PRP is injected into the damaged tissues, it stimulates the body to grow new, healthy cells and thus promotes healing. PRP is prepared by deriving blood from the person and then passing it through two stages of centrifugation to separate PRP from red blood cells and platelet-poor plasma. PRP therapy treats patients with chronic tendinitis, osteoarthritis, tendon injuries, acute injuries, hair loss conditions, oral surgery, and plastic surgery. This therapy does not provide immediate results.

MARKET DYNAMICS

PRP therapy's various advantages like little or no pain, faster recovery, and no scar tissue over surgery are the key driving force behind this market's growth. The simplicity of this therapy will further propel its use in place of transplants. Rising incidences of sports-related injuries and increased adoption of cosmetic procedures will boost the growth of this market. PRP is becoming very popular among the geriatric community since there is absolutely no risk of infection or allergic reactions involved in the process. Growing awareness about the efficiency of platelet-rich plasma treatment in dental health will be a market booster. PRP's single major drawback is its ineffectiveness in treating areas other than the elbow, muscles, and tendons.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Platelet Rich Plasma. The growth and trends of Platelet Rich Plasma industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Platelet Rich Plasma market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

Pure-PRP
Leukocyte-rich PRP
Pure-PRF

By Origin

Autologous
Allogeneic
Homologous

By Application

Orthopedic Surgery
Cosmetic Surgery
General Surgery
Neurosurgery
Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Platelet Rich Plasma market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Platelet Rich Plasma market include Zimmer Biomet Holdings Inc., AdiStem Ltd., ISTO Biologics, ThermoGenesis Holdings Inc., Stryker Corporation, Exactech Inc., EmCyte Corporation, Regen Lab, Arthrex Inc., Terumo BCT, Inc. (Terumo Corporation), DePuy Synthes Companies (Johnson & Johnson), APEX Biologix LLC. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. PLATELET RICH PLASMA - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Type
- 3.7.2 Market Attractiveness Analysis By Origin
- 3.7.3 Market Attractiveness Analysis By Application
- 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL PLATELET RICH PLASMA MARKET ANALYSIS BY TYPE

5.1. Overview By Type
5.2. Historical and Forecast Data Analysis By Type
5.3. Pure-PRP Historic and Forecast Sales By Regions
5.4. Leukocyte-rich PRP Historic and Forecast Sales By Regions
5.5. Pure-PRF Historic and Forecast Sales By Regions

6. GLOBAL PLATELET RICH PLASMA MARKET ANALYSIS BY ORIGIN

6.1. Overview By Origin
6.2. Historical and Forecast Data Analysis By Origin
6.3. Autologous Historic and Forecast Sales By Regions
6.4. Allogeneic Historic and Forecast Sales By Regions
6.5. Homologous Historic and Forecast Sales By Regions

7. GLOBAL PLATELET RICH PLASMA MARKET ANALYSIS BY APPLICATION

7.1. Overview By Application
7.2. Historical and Forecast Data Analysis By Application
7.3. Orthopedic Surgery Historic and Forecast Sales By Regions
7.4. Cosmetic Surgery Historic and Forecast Sales By Regions
7.5. General Surgery Historic and Forecast Sales By Regions
7.6. Neurosurgery Historic and Forecast Sales By Regions
7.7. Others Historic and Forecast Sales By Regions

8. GLOBAL PLATELET RICH PLASMA MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1 Overview, Historic and Forecast Data Sales Analysis
- 8.3.2 North America By Segment Sales Analysis
- 8.3.3 North America By Country Sales Analysis
- 8.3.4 United States Sales Analysis
- 8.3.5 Canada Sales Analysis
- 8.3.6 Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1 Overview, Historic and Forecast Data Sales Analysis
- 8.4.2 Europe By Segment Sales Analysis
- 8.4.3 Europe By Country Sales Analysis
- 8.4.4 United Kingdom Sales Analysis
- 8.4.5 France Sales Analysis
- 8.4.6 Germany Sales Analysis
- 8.4.7 Italy Sales Analysis
- 8.4.8 Russia Sales Analysis
- 8.4.9 Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1 Overview, Historic and Forecast Data Sales Analysis
- 8.5.2 Asia Pacific By Segment Sales Analysis
- 8.5.3 Asia Pacific By Country Sales Analysis
- 8.5.4 China Sales Analysis
- 8.5.5 India Sales Analysis
- 8.5.6 Japan Sales Analysis
- 8.5.7 South Korea Sales Analysis
- 8.5.8 Australia Sales Analysis
- 8.5.9 South East Asia Sales Analysis
- 8.5.10 Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1 Overview, Historic and Forecast Data Sales Analysis
- 8.6.2 Latin America By Segment Sales Analysis
- 8.6.3 Latin America By Country Sales Analysis
- 8.6.4 Brazil Sales Analysis
- 8.6.5 Argentina Sales Analysis
- 8.6.6 Peru Sales Analysis
- 8.6.7 Chile Sales Analysis
- 8.6.8 Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1 Overview, Historic and Forecast Data Sales Analysis
- 8.7.2 Middle East & Africa By Segment Sales Analysis
- 8.7.3 Middle East & Africa By Country Sales Analysis
- 8.7.4 Saudi Arabia Sales Analysis
- 8.7.5 UAE Sales Analysis
- 8.7.6 Israel Sales Analysis
- 8.7.7 South Africa Sales Analysis
- 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE PLATELET RICH PLASMA COMPANIES

9.1. Platelet Rich Plasma Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10. COMPANY PROFILES OF PLATELET RICH PLASMA INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. Zimmer Biomet Holdings Inc.
- 10.3.1 Company Overview
- 10.3.2 Company Revenue
- 10.3.3 Products
- 10.3.4 Recent Developments
10.4. AdiStem Ltd.
- 10.4.1 Company Overview
- 10.4.2 Company Revenue
- 10.4.3 Products
- 10.4.4 Recent Developments
10.5. ISTO Biologics
- 10.5.1 Company Overview
- 10.5.2 Company Revenue
- 10.5.3 Products
- 10.5.4 Recent Developments
10.6. ThermoGenesis Holdings Inc.
- 10.6.1 Company Overview
- 10.6.2 Company Revenue
- 10.6.3 Products
- 10.6.4 Recent Developments
10.7. Stryker Corporation
- 10.7.1 Company Overview
- 10.7.2 Company Revenue
- 10.7.3 Products
- 10.7.4 Recent Developments
10.8. Exactech Inc.
- 10.8.1 Company Overview
- 10.8.2 Company Revenue
- 10.8.3 Products
- 10.8.4 Recent Developments
10.9. EmCyte Corporation
- 10.9.1 Company Overview
- 10.9.2 Company Revenue
- 10.9.3 Products
- 10.9.4 Recent Developments
10.10. Regen Lab
- 10.10.1 Company Overview
- 10.10.2 Company Revenue
- 10.10.3 Products
- 10.10.4 Recent Developments
10.11. Arthrex Inc.
- 10.11.1 Company Overview
- 10.11.2 Company Revenue
- 10.11.3 Products
- 10.11.4 Recent Developments
10.12. Terumo BCT Inc. (Terumo Corporation)
- 10.12.1 Company Overview
- 10.12.2 Company Revenue
- 10.12.3 Products
- 10.12.4 Recent Developments
10.13. DePuy Synthes Companies (Johnson & Johnson)
- 10.13.1 Company Overview
- 10.13.2 Company Revenue
- 10.13.3 Products
- 10.13.4 Recent Developments
10.14. APEX Biologix LLC
- 10.14.1 Company Overview
- 10.14.2 Company Revenue
- 10.14.3 Products
- 10.14.4 Recent Developments